The NCCP National Medical Oncology and Haemato-oncology Programmes aim to ensure that the needs of the anticipated increased incidence in cancer diagnosis and requirements for treatment continue to be met. The national Medical Oncology and Haemato-oncology Programmes incorporates a number of initiatives aimed at coordinating and managing cancer drug services, ensuring appropriate access to and monitoring of cancer drug use and ensuring that appropriate forward-planning is undertaken to meet future requirements.
Information on the work of the programmes is available by clicking the links on the left and below.
Cancer Drug Management Programme
Chimeric Antigen Receptor T-Cell (CAR-T)
Clinical Trials
Contact the National Medical Oncology and Haemato-oncology Programmes
Dose Banding for Systemic Anticancer Therapy
Haemato-oncology Patient Pathways
Molecular Diagnostics (Drugs) Advisory Group
National Meeting
NCCP Systemic Anti-Cancer Therapy Model of Care
NCCP Technology Review Committee
National Cancer Information System (NCIS)
Oncology Medication Safety Review
Peptide Receptor Radionuclide Therapy (PRRT)
SACT Guidance, Documents and Resources
